<DOC>
	<DOCNO>NCT02010047</DOCNO>
	<brief_summary>The anaplastic lymphoma kinase gene ( ALK ) mutate approximately 5 % non-small cell lung cancer . Testing gene important drug know ALK inhibitor show significantly delay progression ALK-mutated lung cancer . There number way test presence ALK gene lung cancer biopsy tissue . One method involve make slide stain detect ALK protein . This call immunohistochemistry . Another method call fluorescence situ hybridization ( FISH ) use detect rearrangement ALK gene associate lung cancer . Although test widely use test ALK gene abnormality , technique may always find ALK gene mutation sensitive enough enough cancer cell present lung biopsy . This study perform determine technique call quantitation polymerase chain reaction ( qPCR ) accurate well find ALK gene mutation lung cancer biopsy tissue .</brief_summary>
	<brief_title>Comparison qPCR IHC FISH Detection ALK Fusion Mutations FFPE Tissue From NSCLC Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>You confirm diagnosis nonsquamous , nonendocrine nonsmall cell lung cancer . Your cancer biopsy sufficient cancer cell test ( Epidermal Growth Factor Receptor ( EGFR ) mutation , ALK fusion gene abnormality research ALK test . Your lung cancer biopsy determine mutation EGFR gene . You 19 year old old . You fully understand study give inform consent participate demonstrate signing consent .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Anaplastic lymphoma kinase gene</keyword>
	<keyword>Polymerase chain reaction</keyword>
	<keyword>Immunohistochemistry</keyword>
	<keyword>Fluorescence situ hybridization</keyword>
</DOC>